EyePoint Pharmaceuticals Inc. buy Robert W. Baird
Start price
11.11.24
/
50%
€10.87
Target price
11.11.25
€30.99
Performance (%)
-8.27%
End price
12.11.25
€9.97
Summary
This prediction ended on 12.11.25 with a price of €9.97. With a performance of -8.27%, the BUY prediction by Robert_W__Baird finished with a loss. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 8.182% | 8.182% | 148.798% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by Robert_W__Baird for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $38.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Robert_W__Baird for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.75
08.05.24
08.05.24
€35.34
08.05.25
08.05.25
-48.52%
09.05.25
09.05.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
20.04.23
20.04.23
-
20.04.24
20.04.24
205.00%
21.04.24
21.04.24